Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 12270
Target5-hydroxytryptamine receptor 2A(Human)
Diamond Therapeutics Inc.

US Patent
LigandPNGBDBM705326(US20240279226, Example 12)
Affinity DataIC50: 0.0400nMAssay Description:Compounds of the present application bind to the 5-HT2 receptor subtypes in the following assays: Compounds of the invention are tested on 5-HT2A and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Diamond Therapeutics Inc.

US Patent
LigandPNGBDBM50056445(lisuride, (S) | lisuride | N'-((8alpha)-9,10-Dideh...)
Affinity DataIC50: 0.970nMAssay Description:Compounds of the present application bind to the 5-HT2 receptor subtypes in the following assays: Compounds of the invention are tested on 5-HT2A and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
Target5-hydroxytryptamine receptor 2A(Human)
Diamond Therapeutics Inc.

US Patent
LigandPNGBDBM21395(3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}e...)
Affinity DataIC50: 2nMAssay Description:Compounds of the present application bind to the 5-HT2 receptor subtypes in the following assays: Compounds of the invention are tested on 5-HT2A and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Diamond Therapeutics Inc.

US Patent
LigandPNGBDBM692199(US20240279226, Example 6a | 1-ethyl-1-methoxy-3- (...)
Affinity DataIC50: 2.60nMAssay Description:Compounds of the present application bind to the 5-HT2 receptor subtypes in the following assays: Compounds of the invention are tested on 5-HT2A and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Diamond Therapeutics Inc.

US Patent
LigandPNGBDBM692200(US20240279226, Example 6b | 1-ethyl-1-methoxy-3- (...)
Affinity DataIC50: 6.5nMAssay Description:Compounds of the present application bind to the 5-HT2 receptor subtypes in the following assays: Compounds of the invention are tested on 5-HT2A and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Diamond Therapeutics Inc.

US Patent
LigandPNGBDBM50056445(lisuride, (S) | lisuride | N'-((8alpha)-9,10-Dideh...)
Affinity DataIC50: 26nMAssay Description:Compounds of the present application bind to the 5-HT2 receptor subtypes in the following assays: Compounds of the invention are tested on 5-HT2A and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Diamond Therapeutics Inc.

US Patent
LigandPNGBDBM705326(US20240279226, Example 12)
Affinity DataIC50: 76nMAssay Description:Compounds of the present application bind to the 5-HT2 receptor subtypes in the following assays: Compounds of the invention are tested on 5-HT2A and...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Diamond Therapeutics Inc.

US Patent
LigandPNGBDBM692199(US20240279226, Example 6a | 1-ethyl-1-methoxy-3- (...)
Affinity DataIC50: 96nMAssay Description:Compounds of the present application bind to the 5-HT2 receptor subtypes in the following assays: Compounds of the invention are tested on 5-HT2A and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Diamond Therapeutics Inc.

US Patent
LigandPNGBDBM10755([3H]-5-HT | 5-Hydroxy Tryptamine | 2-imino-1-methy...)
Affinity DataIC50: 278nMAssay Description:Compounds of the present application bind to the 5-HT2 receptor subtypes in the following assays: Compounds of the invention are tested on 5-HT2A and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Diamond Therapeutics Inc.

US Patent
LigandPNGBDBM692200(US20240279226, Example 6b | 1-ethyl-1-methoxy-3- (...)
Affinity DataIC50: 312nMAssay Description:Compounds of the present application bind to the 5-HT2 receptor subtypes in the following assays: Compounds of the invention are tested on 5-HT2A and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent